Arginine Toothpaste Shows Promise in Reducing Childhood Cavities
A two-year clinical trial demonstrates that arginine-containing toothpaste can significantly reduce dental cavities in children, offering a promising alternative to fluoride-based products.
A recent clinical trial published in JDR Clinical & Translational Research highlights the effectiveness of arginine-containing dentifrices in managing childhood dental caries. The study, conducted over two years across three centers in China, involved 6,000 children aged 10 to 14 who had multiple active cavities. Participants were assigned to use one of three types of toothpaste: 8.0% arginine, 1.5% arginine, or 0.32% sodium fluoride (NaF) as a control.
Results revealed that the toothpaste with 8.0% arginine significantly reduced the number of decayed, missing, and filled surfaces (DMFS) by 26.0%, and decayed, missing, and filled teeth (DMFT) by 25.3%, compared to the NaF control group. In contrast, the 1.5% arginine formulation showed no significant difference from the fluoride control.
These findings indicate that higher concentrations of arginine in toothpaste can be as effective or even more effective than traditional fluoride-based products in preventing dental decay among children with active cavities. While fluoride remains a cornerstone of caries prevention, this research suggests that arginine-based dentifrices could serve as a valuable alternative or complement, especially for populations at higher risk of dental decay.
Further research into optimal concentrations and long-term effects could pave the way for new, more effective oral health strategies. This study underscores the potential of alternative active ingredients in dental care, promoting better oral health outcomes for children worldwide.
Source: https://medicalxpress.com/news/2025-08-arginine-dentifrices-significantly-childhood-caries.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Biomarker Identified for Long COVID Patients
Researchers have identified a potential blood-based biomarker for long COVID, involving the detection of SARS-CoV-2 protein fragments within extracellular vesicles, promising improved diagnosis of this lingering condition.
Short-Term High Fructose Intake May Increase Inflammatory Responses by Boosting Bacterial Toxin Receptors
Recent findings reveal that even short-term high fructose consumption can increase bacterial toxin receptors on immune cells, potentially elevating inflammation risk. Learn how dietary choices impact immune health and metabolic disease susceptibility.
Non-Antibiotic Medications Can Alter the Gut Microbiome and Impact Health
New research uncovers how common non-antibiotic medications can disrupt the gut microbiome, potentially increasing infection risks and affecting immune response. Discover the implications for health and personalized medicine.
GLP-1 Receptor Agonists Show Promise in Reducing Symptoms of Hidradenitis Suppurativa
Recent research shows that GLP-1 receptor agonists may significantly reduce symptoms and improve quality of life in patients with hidradenitis suppurativa, a challenging chronic skin condition. Learn more about this innovative approach.